Mustapha JA, Katzen BT, Neville RF, Lookstein RA, Zeller T, Miller LE, et al. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018;7(16): e009724.

Article  PubMed  PubMed Central  Google Scholar 

Scully RE, Arnaoutakis DJ, DeBord SA, Semel M, Nguyen LL. Estimated annual health care expenditures in individuals with peripheral arterial disease. J Vasc Surg. 2018;67(2):558–67.

Article  PubMed  Google Scholar 

Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171–91.

Article  PubMed  PubMed Central  Google Scholar 

Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–30.

Article  PubMed  Google Scholar 

Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.

Article  PubMed  Google Scholar 

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 Jan;45 Suppl S:S5–67.

Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015 Mar;61(3 Suppl):2S-41S.

Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(6):1642-1651.e3.

Article  PubMed  Google Scholar 

Farber A, Eberhardt RT. The current state of critical limb ischemia: a systematic review. JAMA Surg. 2016;151(11):1070–7.

Article  PubMed  Google Scholar 

Kim ES, Sharma AM, Scissons R, Dawson D, Eberhardt RT, Gerhard-Herman M, et al. Interpretation of peripheral arterial and venous Doppler waveforms: a consensus statement from the Society for Vascular Medicine and Society for Vascular Ultrasound. Vasc Med. 2020;25(5):484–506.

Article  PubMed  Google Scholar 

Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000 Jan;31(1 Pt 2):S1–296.

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33.

Butcher HR, Jaffe BM. Treatment of aortoiliac arterial occlusive disease by endarterectomy. Ann Surg. 1971;173(6):925–32.

Article  PubMed  PubMed Central  Google Scholar 

Inahara T. Evaluation of endarterectomy for aortoiliac and aortoiliofemoral occlusive disease. Arch Surg. 1975;110(12):1458–64.

Article  PubMed  CAS  Google Scholar 

Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48(4):872–7.

Article  PubMed  Google Scholar 

Sidawy AN, Perler BA. Aortoiliac disease: direct reconstruction. In: Rutherford’s Vascular surgery and endovascular therapy. 10th Edition. Philadelphia: Elsevier; 2023.

Rollins DL, Towne JB, Bernhard VM, Baum PL. Endarterectomized superficial femoral artery as an arterial patch. Arch Surg. 1985;120(3):367–9.

Article  PubMed  CAS  Google Scholar 

Soden PA, Zettervall SL, Shean KE, Deery SE, Kalish JA, Healey CT, et al. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes. J Vasc Surg. 2017;65(3):711-719.e1.

Article  PubMed  Google Scholar 

Malgor RD, Ricotta JJ, Bower TC, Oderich GS, Kalra M, Duncan AA, et al. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann Vasc Surg. 2012;26(7):946–56.

Article  PubMed  Google Scholar 

Siracuse JJ, Gill HL, Schneider DB, Graham AR, Connolly PH, Jones DW, et al. Assessing the perioperative safety of common femoral endarterectomy in the endovascular era. Vasc Endovascular Surg. 2014;48(1):27–33.

Article  PubMed  Google Scholar 

Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes. J Endovasc Ther. 2004;11(3):281–6.

Article  PubMed  Google Scholar 

Siracuse JJ, Van Orden K, Kalish JA, Eslami MH, Schermerhorn ML, Patel VI, et al. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg. 2017;65(4):1039–46.

Article  PubMed  Google Scholar 

de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg. 1997;26(4):558–69.

Article  PubMed  Google Scholar 

Chiesa R, Marone EM, Tshomba Y, Logaldo D, Castellano R, Melissano G. Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease. Ann Vasc Surg. 2009;23(6):764–9.

Article  PubMed  Google Scholar 

DeCarlo C, Boitano LT, Schwartz SI, Lancaster RT, Conrad MF, Eagleton MJ, et al. Laparotomy- and groin-associated complications are common after aortofemoral bypass and contribute to reintervention. J Vasc Surg. 2020;72(6):1976–86.

Article  PubMed  Google Scholar 

Sharma G, Scully RE, Shah SK, Madenci AL, Arnaoutakis DJ, Menard MT, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2018;68(6):1796-1804.e2.

Article  PubMed  Google Scholar 

Abdelkarim AH, Dakour-Aridi H, Gurakar M, Nejim B, Locham S, Malas MB. Association between statin use and perioperative mortality after aortobifemoral bypass in patients with aortoiliac occlusive disease. J Vasc Surg. 2019;70(2):509–15.

Article  PubMed  Google Scholar 

Mwipatayi BP, Thomas S, Wong J, Temple SEL, Vijayan V, Jackson M, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2011;54(6):1561–70.

Article  PubMed  Google Scholar 

Dorigo W, Piffaretti G, Benedetto F, Tarallo A, Castelli P, Spinelli F, et al. A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. J Vasc Surg. 2017;65(1):99–107.

Article  PubMed  Google Scholar 

Chaikof EL, Cambria RP, editors. Extraanatomic repair of aortoiliac occlusive disease. In: Atlas of vascular surgery and endovascular therapy: anatomy and technique. Philadelphia, PA: Elsevier Saunders; 2014.

Taylor LM, Park TC, Edwards JM, Yeager RA, McConnell DC, Moneta GA, et al. Acute disruption of polytetrafluoroethylene grafts adjacent to axillary anastomoses: a complication of axillofemoral grafting. J Vasc Surg. 1994 Oct;20(4):520–6; discussion 526–528.

Passman MA, Taylor LM, Moneta GL, Edwards JM, Yeager RA, McConnell DB, et al. Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 1996 Feb;23(2):263–9; discussion 269–271.

Harrington ME, Harrington EB, Haimov M, Schanzer H, Jacobson JH. Axillofemoral bypass: compromised bypass for compromised patients. J Vasc Surg. 1994;20(2):195–201.

Article  PubMed  CAS  Google Scholar 

Schneider JR, McDaniel MD, Walsh DB, Zwolak RM, Cronenwett JL. Axillofemoral bypass: outcome and hemodynamic results in high-risk patients. J Vasc Surg. 1992 Jun;15(6):952–62; discussion 962–963.

Martin D, Katz SG. Axillofemoral bypass for aortoiliac occlusive disease. Am J Surg. 2000;180(2):100–3.

Article  PubMed  CAS  Google Scholar 

Taylor LM, Moneta GL, McConnell D, Yeager RA, Edwards JM, Porter JM. Axillofemoral grafting with externally supported polytetrafluoroethylene. Arch Surg. 1994 Jun;129(6):588–94; discussion 594–595.

Samson RH, Showalter DP, Lepore MR, Nair DG, Dorsay DA, Morales RE. Improved patency after axillofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2018;68(5):1430–7.

Article  PubMed  Google Scholar 

Levin SR, Farber A, King EG, Beck AW, Osborne NH, DeMartino RR, et al. Outcomes of axillofemoral bypass for intermittent claudication. J Vasc Surg. 2022;75(5):1687-1694.e4.

Article  PubMed  Google Scholar 

Johnson WC, Lee KK. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141. J Vasc Surg. 1999 Dec;30(6):1077–83.

Flanigan DP, Pratt DG, Goodreau JJ, Burnham SJ, Yao JS, Bergan JJ. Hemodynamic and angiographic guidelines in selection of patients for femorofemoral bypass. Arch Surg. 1978;113(11):1257–62.

Article  PubMed  CAS  Google Scholar 

Aburahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33(2 Suppl):S93-99.

Article  PubMed  CAS  Google Scholar 

Ricco JB, Probst H, French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008 Jan;47(1):45–53; discussion 53–54.

Schneider JR, Besso SR, Walsh DB, Zwolak RM, Cronenwett JL. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results. J Vasc Surg. 1994 Jan;19(1):43–55; discussion 55–57.

Plecha FR, Plecha FM. Femorofemoral bypass grafts: ten-year experience. J Vasc Surg. 1984;1(4):555–61.

Article  PubMed  CAS  Google Scholar 

Hinchliffe RJ, Alric P, Wenham PW, Hopkinson BR. Durability of femorofemoral bypass grafting after aortouniiliac endovascular aneurysm repair. J Vasc Surg. 2003;38(3):498–503.

Article  PubMed  Google Scholar 

Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3(1):104–14.

Article  PubMed  CAS  Google Scholar 

Pomposelli FB, Jepsen SJ, Gibbons GW, Campbell DR, Freeman DV, Miller A, et al. Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg. 1990 Jun;11(6):745–51; discussion 751–752.

Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006 Apr;43(4):742–51; discussion 751.

Byrne J, Darling RC, Chang BB, Paty PS, Kreienberg PB, Lloyd WE, et al. Infrainguinal arterial reconstruction for claudication: is it worth the risk? An analysis of 409 procedures. J Vasc Surg. 1999 Feb;29(2):259–67; discussion 267–269.

Kobayashi M, Hida K, Shikata H, Sakamoto S, Matsubara J. Long term outcome of femoropopliteal bypass for claudication and critical ischemia. Asian Cardiovasc Thorac Ann. 2004;12(3):208–12.

Article  PubMed  Google Scholar 

Cull DL, Langan EM, Gray BH, Johnson B, Taylor SM. Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg. 2010 May;210(5):555–61, 561–3.

Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005